TABLE 2.
Treatment‐related adverse events
| Grade (N = 13) | ||||
|---|---|---|---|---|
| 1–2 | 3–4 | |||
| No. | % | No. | % | |
| Amylase increase | 0 | 0 | 1 | 7.6 |
| Lipase increase | 0 | 0 | 1 | 7.6 |
| Rash | 3 | 23 | 1 | 7.6 |
| Dry skin | 2 | 15.3 | 0 | 0 |
| Pruritus | 1 | 7.6 | 0 | 0 |
| Chills | 1 | 7.6 | 0 | 0 |
| Hot Flashes | 1 | 7.6 | 0 | 0 |
| Diarrhea | 1 | 7.6 | 2 | 15.3 |
| Constipation | 1 | 7.6 | 0 | 0 |
| Abdominal pain | 1 | 7.6 | 0 | 0 |
| Fatigue | 7 | 53.8 | 1 | 7.6 |
| Malaise | 2 | 15.3 | 0 | 0 |
| Arthralgia | 2 | 15.3 | 0 | 0 |
| Myalgia | 2 | 15.3 | 0 | 0 |
| Hypothyroidism | 1 | 7.6 | 0 | 0 |
| Headache | 1 | 7.6 | 0 | 0 |
| Nausea | 1 | 7.6 | 0 | 0 |
| Dysgeusia | 1 | 7.6 | 0 | 0 |
| Anorexia | 3 | 23 | 0 | 0 |
| Dry mouth | 1 | 7.6 | 0 | 0 |
| Peripheral sensory neuropathy | 1 | 7.6 | 0 | 0 |
| Eye disorder (Pain, Irritation) | 1 | 7.6 | 0 | 0 |